Enovix Corp has a consensus price target of $29.27, established from looking at the 45 latest analyst ratings. The last 3 analyst ratings were released from EF Hutton, Craig-Hallum, and B. Riley Securities on May 2, 2024, May 2, 2024, and April 30, 2024. With an average price target of $18.33 between EF Hutton, Craig-Hallum, and B. Riley Securities, there's an implied 90.58% upside for Enovix Corp from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
05/02/2024 | Buy Now | 149.48% | EF Hutton | Tim Moore | $24 → $24 | Maintains | Buy | Get Alert |
05/02/2024 | Buy Now | 55.93% | Craig-Hallum | Anthony Stoss | $20 → $15 | Maintains | Buy | Get Alert |
04/30/2024 | Buy Now | 66.32% | B. Riley Securities | Christopher Souther | $18 → $16 | Maintains | Buy | Get Alert |
04/26/2024 | Buy Now | 24.74% | JP Morgan | Bill Peterson | $18 → $12 | Maintains | Overweight | Get Alert |
04/25/2024 | Buy Now | 211.85% | Cantor Fitzgerald | Derek Soderberg | → $30 | Reiterates | Overweight → Overweight | Get Alert |
02/21/2024 | Buy Now | 149.48% | EF Hutton | Tim Moore | → $24 | Reiterates | Buy → Buy | Get Alert |
02/21/2024 | Buy Now | 211.85% | Cantor Fitzgerald | Derek Soderberg | → $30 | Reiterates | Overweight → Overweight | Get Alert |
02/21/2024 | Buy Now | 76.72% | Canaccord Genuity | George Gianarikas | → $17 | Reiterates | Buy → Buy | Get Alert |
01/18/2024 | Buy Now | 211.85% | Cantor Fitzgerald | Derek Soderberg | → $30 | Reiterates | Overweight → Overweight | Get Alert |
11/08/2023 | Buy Now | 211.85% | Cantor Fitzgerald | Derek Soderberg | $28 → $30 | Maintains | Overweight | Get Alert |
09/21/2023 | Buy Now | 128.69% | EF Hutton | Tim Moore | → $22 | Reiterates | Buy → Buy | Get Alert |
09/08/2023 | Buy Now | 191.06% | Cantor Fitzgerald | Derek Soderberg | → $28 | Reiterates | Overweight → Overweight | Get Alert |
07/27/2023 | Buy Now | 191.06% | Craig-Hallum | Anthony Stoss | $15 → $28 | Maintains | Buy | Get Alert |
07/27/2023 | Buy Now | 128.69% | EF Hutton | Tim Moore | $21 → $22 | Reiterates | Buy → Buy | Get Alert |
07/21/2023 | Buy Now | 107.9% | TD Cowen | Gabe Daoud | $19 → $20 | Downgrade | Outperform → Market Perform | Get Alert |
07/20/2023 | Buy Now | 159.88% | B. Riley Securities | Christopher Souther | $18 → $25 | Maintains | Buy | Get Alert |
07/05/2023 | Buy Now | 118.3% | EF Hutton | Chip Moore | → $21 | Assumes | → Buy | Get Alert |
06/28/2023 | Buy Now | 159.88% | Cantor Fitzgerald | Derek Soderberg | → $25 | Reiterates | Overweight → Overweight | Get Alert |
06/16/2023 | Buy Now | 107.9% | Canaccord Genuity | George Gianarikas | → $20 | Reiterates | Buy → Buy | Get Alert |
04/27/2023 | Buy Now | 274.22% | Oppenheimer | Colin Rusch | → $36 | Reiterates | → Outperform | Get Alert |
04/27/2023 | Buy Now | 118.3% | EF Hutton | Chip Moore | $18 → $21 | Maintains | Buy | Get Alert |
03/29/2023 | Buy Now | 87.11% | EF Hutton | Chip Moore | → $18 | Reiterates | → Buy | Get Alert |
03/10/2023 | Buy Now | 159.88% | Cantor Fitzgerald | Derek Soderberg | → $25 | Reiterates | → Overweight | Get Alert |
02/23/2023 | Buy Now | 55.93% | Craig-Hallum | Anthony Stoss | $23 → $15 | Maintains | Buy | Get Alert |
02/23/2023 | Buy Now | 159.88% | Piper Sandler | Alexander Potter | $22.5 → $25 | Maintains | Overweight | Get Alert |
02/23/2023 | Buy Now | 87.11% | EF Hutton | Chip Moore | → $18 | Reiterates | → Buy | Get Alert |
01/27/2023 | Buy Now | 87.11% | EF Hutton | Chip Moore | $23 → $18 | Maintains | Buy | Get Alert |
01/26/2023 | Buy Now | 66.32% | JP Morgan | Bill Peterson | $28 → $16 | Maintains | Overweight | Get Alert |
01/23/2023 | Buy Now | 133.89% | Piper Sandler | Alexander Potter | $26.5 → $22.5 | Maintains | Overweight | Get Alert |
01/11/2023 | Buy Now | 107.9% | Canaccord Genuity | George Gianarikas | → $20 | Initiates | → Buy | Get Alert |
12/02/2022 | Buy Now | 97.51% | B. Riley Securities | Christopher Souther | → $19 | Initiates | → Buy | Get Alert |
11/04/2022 | Buy Now | 139.09% | Janney Montgomery Scott | Sean Milligan | → $23 | Initiates | → Buy | Get Alert |
10/28/2022 | Buy Now | 159.88% | EF Hutton | Chip Moore | → $25 | Initiates | → Buy | Get Alert |
08/24/2022 | Buy Now | 274.22% | Cowen & Co. | Gabe Daoud | $19 → $36 | Maintains | Outperform | Get Alert |
08/22/2022 | Buy Now | 939.5% | Loop Capital | Ananda Baruah | $50 → $100 | Maintains | Buy | Get Alert |
08/11/2022 | Buy Now | 159.88% | Northland Capital Markets | Gus Richard | $22 → $25 | Maintains | Outperform | Get Alert |
08/11/2022 | Buy Now | 159.88% | Craig-Hallum | Anthony Stoss | $20 → $25 | Maintains | Buy | Get Alert |
08/05/2022 | Buy Now | 107.9% | JP Morgan | Bill Peterson | → $20 | Initiates | → Overweight | Get Alert |
06/24/2022 | Buy Now | 107.9% | Cowen & Co. | Gabe Daoud | $24 → $20 | Maintains | Outperform | Get Alert |
03/04/2022 | Buy Now | 263.83% | Craig-Hallum | Anthony Stoss | $50 → $35 | Maintains | Buy | Get Alert |
01/04/2022 | Buy Now | 232.64% | Cowen & Co. | Gabe Daoud | → $32 | Initiates | → Outperform | Get Alert |
12/17/2021 | Buy Now | 305.41% | Piper Sandler | Greg Tuttle | — | Initiates | → Overweight | Get Alert |
12/02/2021 | Buy Now | 419.75% | Craig-Hallum | Anthony Stoss | — | Initiates | → Buy | Get Alert |
08/17/2021 | Buy Now | 232.64% | Oppenheimer | Colin Rusch | — | Initiates | → Outperform | Get Alert |
07/28/2021 | Buy Now | 107.9% | TD Cowen | Gabe Daoud | $19 → $20 | Downgrade | Outperform → Market Perform | Get Alert |
The latest price target for Enovix (NASDAQ: ENVX) was reported by EF Hutton on May 2, 2024. The analyst firm set a price target for $24.00 expecting ENVX to rise to within 12 months (a possible 149.48% upside). 19 analyst firms have reported ratings in the last year.
The latest analyst rating for Enovix (NASDAQ: ENVX) was provided by EF Hutton, and Enovix maintained their buy rating.
There is no last upgrade for Enovix.
The last downgrade for Enovix Corp happened on July 21, 2023 when TD Cowen changed their price target from $19 to $20 for Enovix Corp.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Enovix, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Enovix was filed on May 2, 2024 so you should expect the next rating to be made available sometime around May 2, 2025.
While ratings are subjective and will change, the latest Enovix (ENVX) rating was a maintained with a price target of $24.00 to $24.00. The current price Enovix (ENVX) is trading at is $9.62, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.